1. Home
  2. COHN vs CCEL Comparison

COHN vs CCEL Comparison

Compare COHN & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$18.24

Market Cap

40.3M

Sector

Finance

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.41

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
CCEL
Founded
1999
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.3M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
COHN
CCEL
Price
$18.24
$3.41
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
32.8K
14.0K
Earning Date
03-09-2026
02-27-2026
Dividend Yield
5.52%
11.83%
EPS Growth
6.29
N/A
EPS
2.50
N/A
Revenue
$185,475,000.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$7.25
N/A
Revenue Growth
107.11
N/A
52 Week Low
$6.10
$3.10
52 Week High
$32.60
$8.79

Technical Indicators

Market Signals
Indicator
COHN
CCEL
Relative Strength Index (RSI) 47.88 38.45
Support Level $17.34 $3.29
Resistance Level $19.25 $3.57
Average True Range (ATR) 1.35 0.17
MACD -0.19 0.01
Stochastic Oscillator 29.58 20.52

Price Performance

Historical Comparison
COHN
CCEL

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: